RU2006141834A - Суммарные экстракты из andrographis paniculata - Google Patents
Суммарные экстракты из andrographis paniculata Download PDFInfo
- Publication number
- RU2006141834A RU2006141834A RU2006141834/14A RU2006141834A RU2006141834A RU 2006141834 A RU2006141834 A RU 2006141834A RU 2006141834/14 A RU2006141834/14 A RU 2006141834/14A RU 2006141834 A RU2006141834 A RU 2006141834A RU 2006141834 A RU2006141834 A RU 2006141834A
- Authority
- RU
- Russia
- Prior art keywords
- deoxyandrographolide
- deoxy
- neoandrographolide
- extract contains
- andrografolida
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
Claims (21)
1. Способ ингибирования экспрессии TNF α у нуждающегося в этом субъекта, включающий введение субъекту эффективного количества экстракта из Andrographis paniculata.
2. Способ по п.1, где экстракт содержит андрографолид, 14-дезоксиандрографолид, 14-дезокси-11,12-дегидроандрографолид и неоандрографолид.
3. Способ по п.2, где экстракт содержит 2-20 мас.% андрографолида, 1-6 мас.% 14-дезоксиандрографолида, 1-12 мас.% 14-дезокси-11,12-дегидроандрографолида и 1-5 мас.% неоандрографолида.
4. Способ по п.3, где экстракт содержит 3-8 мас.% андрографолида, 3-5 мас.% 14-дезоксиандрографолида, 7-9 мас.% 14-дезокси-11,12-дегидроандрографолида и 2-4 мас.% неоандрографолида.
5. Способ по п.4, где экстракт содержит 4,2 мас.% андрографолида, 4,4 мас.% 14-дезоксиандрографолида, 8 мас.% 14-дезокси-11,12-дегидроандрографолида и 2,1 мас.% неоандрографолида.
6. Способ ингибирования экспрессии IL-1β у нуждающегося в этом субъекта, включающий введение субъекту эффективного количества экстракта из Andrographis paniculata.
7. Способ по п.6, где экстракт содержит андрографолид, 14-дезоксиандрографолид, 14-дезокси-11,12-дегидроандрографолид и неоандрографолид.
8. Способ по п.7, где экстракт содержит 2-20 мас.% андрографолида, 1-6 мас.% 14-дезоксиандрографолида, 1-12 мас.% 14-дезокси-11,12-дегидроандрографолида и 1-5 мас.% неоандрографолида.
9. Способ по п.8, где экстракт содержит 3-8 мас.% андрографолида, 3-5 мас.% 14-дезоксиандрографолида, 7-9 мас.% 14-дезокси-11,12-дегидроандрографолида и 2-4 мас.% неоандрографолида.
10. Способ по п.9, где экстракт содержит 4,2 мас.% андрографолида, 4,4 мас.% 14-дезоксиандрографолида, 8 мас.% 14-дезокси-11,12-дегидроандрографолида и 2,1 мас.% неоандрографолида.
11. Способ лечения воспалительного заболевания кишечника у нуждающегося в этом субъекта, включающий введение субъекту эффективного количества экстракта из Andrographis paniculata.
12. Способ по п.11, где экстракт содержит андрографолид, 14-дезоксиандрографолид, 14-дезокси-11,12-дегидроандрографолид и неоандрографолид.
13. Способ по п.12, где экстракт содержит 2-20 мас.% андрографолида, 1-6 мас.% 14-дезоксиандрографолида, 1-12 мас.% 14-дезокси-11,12-дегидроандрографолида и 1-5 мас.% неоандрографолида.
14. Способ по п.13, где экстракт содержит 3-8 мас.% андрографолида, 3-5 мас.% 14-дезоксиандрографолида, 7-9 мас.% 14-дезокси-11,12-дегидроандрографолида и 2-4 мас.% неоандрографолида.
15. Способ по п.14, где экстракт содержит 4,2 мас.% андрографолида, 4,4 мас.% 14-дезоксиандрографолида, 8 мас.% 14-дезокси-11,12-дегидроандрографолида и 2,1 мас.% неоандрографолида.
16. Способ по п.11, где воспалительным заболеванием кишечника является болезнь Крона.
17. Способ по п.16, где экстракт содержит андрографолид, 14-дезоксиандрографолид, 14-дезокси-11,12-дегидроандрографолид и неоандрографолид.
18. Способ по п.17, где экстракт содержит 2-20 мас.% андрографолида, 1-6 мас.% 14-дезоксиандрографолида, 1-12 мас.% 14-дезокси-11,12-дегидроандрографолида и 1-5 мас.% неоандрографолида.
19. Способ по п.11, где воспалительным заболеванием кишечника является язвенный колит.
20. Способ по п.19, где экстракт содержит андрографолид, 14-дезоксиандрографолид, 14-дезокси-11,12-дегидроандрографолид и неоандрографолид.
21. Способ по п.20, где экстракт содержит 2-20 мас.% андрографолида, 1-6 мас.% 14-дезоксиандрографолида, 1-12 мас.% 14-дезокси-11,12-дегидроандрографолида и 1-5 мас.% неоандрографолида.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56647704P | 2004-04-28 | 2004-04-28 | |
US60/566,477 | 2004-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006141834A true RU2006141834A (ru) | 2008-06-10 |
RU2383353C2 RU2383353C2 (ru) | 2010-03-10 |
Family
ID=35242143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006141834/14A RU2383353C2 (ru) | 2004-04-28 | 2005-04-26 | Суммарные экстракты из andrographis paniculata |
Country Status (14)
Country | Link |
---|---|
US (3) | US7341748B2 (ru) |
EP (1) | EP1747008B1 (ru) |
JP (1) | JP5221128B2 (ru) |
KR (3) | KR101534844B1 (ru) |
AU (1) | AU2005237550B2 (ru) |
CA (1) | CA2564637C (ru) |
DK (1) | DK1747008T3 (ru) |
ES (1) | ES2534594T3 (ru) |
HU (1) | HUE025117T2 (ru) |
PL (1) | PL1747008T3 (ru) |
PT (1) | PT1747008E (ru) |
RU (1) | RU2383353C2 (ru) |
TW (1) | TWI373340B (ru) |
WO (1) | WO2005104722A2 (ru) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005087223A1 (en) * | 2004-03-11 | 2005-09-22 | Hutchison Medipharma Ltd. | ANDROGRAPHOLIDE AND ANALOGUES AS INHIBITORS OF TNFα AND IL-1βEXPRESSION |
CA2564637C (en) | 2004-04-28 | 2013-09-10 | Hutchison Medipharma Enterprises Limited | Crude extracts from andrographis paniculata |
JP2007176934A (ja) * | 2005-11-30 | 2007-07-12 | Kose Corp | 血小板活性化因子アセチルヒドロラーゼ機能調整剤 |
US20070202164A1 (en) * | 2006-02-28 | 2007-08-30 | Hutchison Medipharma Enterprises Limited | Andrographis Extract Formulations |
EP1882473A1 (en) * | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
US20090117209A1 (en) * | 2007-11-02 | 2009-05-07 | Hutchison Medipharma Enterprises Limited | Andrographis paniculata extract |
EP2411004A4 (en) * | 2009-03-24 | 2012-08-15 | Univ Singapore | USE OF ANDROGRAPHOLIDE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASE AND RESPIRATORY DISEASES |
MD480Z5 (ru) * | 2011-07-07 | 2012-09-30 | Эльвира АНДОН | Метод лечения острого язвенного неспецифического колита |
CN102702147B (zh) * | 2012-06-18 | 2016-06-08 | 辽宁利锋科技开发有限公司 | 穿心莲内酯类似物及其治疗的应用 |
CN103145661B (zh) * | 2013-03-25 | 2014-06-18 | 成都天台山制药有限公司 | 穿心莲内酯的新晶型 |
CN103145660B (zh) * | 2013-03-25 | 2014-09-17 | 成都天台山制药有限公司 | 穿心莲内酯及其制备方法 |
CN103223028A (zh) * | 2013-03-27 | 2013-07-31 | 张宗升 | 中药提取物 |
CN103766901A (zh) * | 2014-01-08 | 2014-05-07 | 浙江大学 | 一种穿心莲丙素在制备减肥食品或药品中的应用 |
JP6386761B2 (ja) * | 2014-03-19 | 2018-09-05 | 花王株式会社 | インボルクリン発現抑制剤 |
MY176459A (en) * | 2016-05-23 | 2020-08-10 | Univ Putra Malaysia | Extract of andrographis paniculata for cognitive enhancement |
WO2018081959A1 (en) * | 2016-11-02 | 2018-05-11 | Nutrition Science Partners Limited | Extracts of andrographis paniculata, methods for preparation and use thereof |
CN107349253A (zh) * | 2017-06-23 | 2017-11-17 | 苏州凌科特新材料有限公司 | 无刺激医用消毒液及其制备方法 |
WO2022058422A1 (en) * | 2020-09-17 | 2022-03-24 | Dsm Ip Assets B.V. | Use of andrographis paniculata extract to protect against air pollution related diseases |
WO2024092327A1 (pt) * | 2022-10-31 | 2024-05-10 | Mey, Angelica Machado | Composição para obtenção de bioativo natural para terapias oncológicas |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1012941B (zh) | 1989-07-29 | 1991-06-26 | 郭如明 | 穿心莲碱水法新工艺 |
US20030059471A1 (en) | 1997-12-15 | 2003-03-27 | Compton Bruce Jon | Oral delivery formulation |
JP2000034233A (ja) * | 1998-07-15 | 2000-02-02 | Sumitomo Forestry Co Ltd | 一酸化窒素産生抑制剤 |
JP2001058969A (ja) * | 1999-08-20 | 2001-03-06 | Nettairin Saisei Gijutsu Kenkyu Kumiai | 一酸化窒素産生抑制剤 |
EA008612B1 (ru) | 2000-07-28 | 2007-06-29 | Иммуфарм Апс | Способ лечения обычной простуды, аллергического ринита и инфекций дыхательных путей |
US6629835B2 (en) | 2000-08-01 | 2003-10-07 | Metaproteomics, Llc | Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 |
US6358526B1 (en) | 2000-08-16 | 2002-03-19 | Rexall Sundown | Method of making tablets and tablet compositions produced therefrom |
US7270835B2 (en) | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20030101076A1 (en) | 2001-10-02 | 2003-05-29 | Zaleski John R. | System for supporting clinical decision making through the modeling of acquired patient medical information |
US6753017B2 (en) | 2001-11-07 | 2004-06-22 | Jrs Pharma Lp | Process for preparing dry extracts |
JP2003171301A (ja) | 2001-11-09 | 2003-06-20 | Mahidol Univ | 歯周炎治療における補助剤としてのカルメグゲル |
JP4669920B2 (ja) | 2002-08-21 | 2011-04-13 | 沖縄県 | 血糖上昇抑制且つ血圧上昇抑制作用を有する機能性素材 |
CN1488376A (zh) | 2003-05-09 | 2004-04-14 | 江西诚志信丰药业有限责任公司 | 一种治疗肠道疾病及鼻窦炎的药物胶囊及其制备方法 |
CN1626076B (zh) | 2003-12-11 | 2010-10-06 | 天津天士力制药股份有限公司 | 一种穿心莲内酯滴丸及其制备方法 |
KR101065608B1 (ko) | 2003-12-29 | 2011-09-19 | 주식회사 엘지생활건강 | 안드로그라폴라이드 또는 안드로그라폴라이드를유효성분으로 함유하는 천심련 추출물을 포함하는가려움증 억제 또는 완화 조성물 |
WO2005087223A1 (en) * | 2004-03-11 | 2005-09-22 | Hutchison Medipharma Ltd. | ANDROGRAPHOLIDE AND ANALOGUES AS INHIBITORS OF TNFα AND IL-1βEXPRESSION |
CA2564637C (en) | 2004-04-28 | 2013-09-10 | Hutchison Medipharma Enterprises Limited | Crude extracts from andrographis paniculata |
EP1758554A1 (en) | 2004-06-12 | 2007-03-07 | Passion For Life Healthcare Limited | Soluble strip for oral or topical adminstration |
CN1628764A (zh) | 2004-08-19 | 2005-06-22 | 贵阳云岩西创药物科技开发有限公司 | 穿心莲制剂及其制备方法 |
US20070202164A1 (en) | 2006-02-28 | 2007-08-30 | Hutchison Medipharma Enterprises Limited | Andrographis Extract Formulations |
US20090117209A1 (en) | 2007-11-02 | 2009-05-07 | Hutchison Medipharma Enterprises Limited | Andrographis paniculata extract |
-
2005
- 2005-04-26 CA CA2564637A patent/CA2564637C/en active Active
- 2005-04-26 RU RU2006141834/14A patent/RU2383353C2/ru active
- 2005-04-26 JP JP2007510891A patent/JP5221128B2/ja not_active Expired - Fee Related
- 2005-04-26 KR KR1020067025043A patent/KR101534844B1/ko active IP Right Grant
- 2005-04-26 HU HUE05742174A patent/HUE025117T2/en unknown
- 2005-04-26 WO PCT/US2005/014288 patent/WO2005104722A2/en active Application Filing
- 2005-04-26 EP EP05742174.5A patent/EP1747008B1/en active Active
- 2005-04-26 KR KR1020137001151A patent/KR101531116B1/ko active IP Right Grant
- 2005-04-26 ES ES05742174.5T patent/ES2534594T3/es active Active
- 2005-04-26 AU AU2005237550A patent/AU2005237550B2/en not_active Ceased
- 2005-04-26 PT PT05742174T patent/PT1747008E/pt unknown
- 2005-04-26 DK DK05742174T patent/DK1747008T3/en active
- 2005-04-26 KR KR1020157010077A patent/KR101536892B1/ko active IP Right Grant
- 2005-04-26 PL PL05742174T patent/PL1747008T3/pl unknown
- 2005-04-27 US US11/116,678 patent/US7341748B2/en not_active Ceased
- 2005-04-27 TW TW094113415A patent/TWI373340B/zh not_active IP Right Cessation
-
2010
- 2010-03-04 US US12/717,260 patent/USRE42718E1/en active Active
-
2011
- 2011-07-22 US US13/189,444 patent/USRE43423E1/en active Active
Also Published As
Publication number | Publication date |
---|---|
US7341748B2 (en) | 2008-03-11 |
USRE42718E1 (en) | 2011-09-20 |
AU2005237550B2 (en) | 2010-09-23 |
ES2534594T3 (es) | 2015-04-24 |
RU2383353C2 (ru) | 2010-03-10 |
EP1747008A2 (en) | 2007-01-31 |
WO2005104722A3 (en) | 2006-03-02 |
JP5221128B2 (ja) | 2013-06-26 |
KR20150047645A (ko) | 2015-05-04 |
KR20070033982A (ko) | 2007-03-27 |
KR101534844B1 (ko) | 2015-07-07 |
KR101531116B1 (ko) | 2015-06-23 |
PT1747008E (pt) | 2015-03-31 |
AU2005237550A1 (en) | 2005-11-10 |
USRE43423E1 (en) | 2012-05-29 |
EP1747008B1 (en) | 2015-01-14 |
KR101536892B1 (ko) | 2015-07-14 |
EP1747008A4 (en) | 2009-04-22 |
JP2007535542A (ja) | 2007-12-06 |
TW200538144A (en) | 2005-12-01 |
US20060246156A1 (en) | 2006-11-02 |
HUE025117T2 (en) | 2016-02-29 |
TWI373340B (en) | 2012-10-01 |
WO2005104722A2 (en) | 2005-11-10 |
KR20130012979A (ko) | 2013-02-05 |
DK1747008T3 (en) | 2015-03-30 |
CA2564637A1 (en) | 2005-11-10 |
PL1747008T3 (pl) | 2015-10-30 |
CA2564637C (en) | 2013-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2006141834A (ru) | Суммарные экстракты из andrographis paniculata | |
Yaeesh et al. | Antihepatotoxic activity of Saussurea lappa extract on D‐galactosamine and lipopolysaccharide‐induced hepatitis in mice | |
CN103961558A (zh) | 一种解酒护肝的铁皮石斛速溶颗粒 | |
CN101675781A (zh) | 一种生姜腌制而成的咸味小菜 | |
CN103860774A (zh) | 一种用于治疗痢疾和痔疮的中药组合物及制法 | |
CN103798451A (zh) | 一种清热泻火凉茶 | |
JP2005530697A5 (ru) | ||
CN103719496B (zh) | 一种山楂叶降脂减肥保健茶及其制备方法 | |
CN104491376A (zh) | 一种治疗丘疹性荨麻疹的中药喷雾剂及其制备方法 | |
CN105878865A (zh) | 一种治疗湿疹的中药 | |
JP2005501923A5 (ru) | ||
CN106538854A (zh) | 一种用于湿热内蕴型羊布氏杆菌的饲料添加剂 | |
CN1633984A (zh) | 即冲型艾洗浴剂 | |
CN105079597A (zh) | 一种用于预防及治疗疥疮的美容养颜养生酒 | |
CN106729474A (zh) | 一种用于治疗外感风寒里热的中药 | |
Dempsey et al. | Excerpt from'Mary Medusa' | |
CN1255133C (zh) | 治疗肝病的胶囊 | |
CN108815418A (zh) | 一种治疗脱肛的中药配方及其制备方法 | |
CN104905051A (zh) | 一种鸡饲料添加剂 | |
CN105639228A (zh) | 一种茶叶粥 | |
CN104173755A (zh) | 用于轻度烫伤但皮肤无破损的中药制剂及制备方法 | |
CN104083485A (zh) | 一种防治畜禽病害的中草药生物制剂及制备方法 | |
CN103341132A (zh) | 一种抗疟药胶囊及其制备方法 | |
CN110237125A (zh) | 一种减肥中药包 | |
CN105770222A (zh) | 一种治疗被壶蜂虿伤的内服草药及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20130902 |